Gujarat Inject (Kerala) Ltd. Hits Upper Circuit on BSE, 27 October 2026

A holder of Gujarat Inject (Kerala) Ltd. (GUJINJEC) saw a higher mark on 27 October 2026, while a would-be buyer found the stock already at its limit. The Gujarat Inject (Kerala) upper circuit was reached on BSE at Rs 10.67, a 4.92% gain on the previous close of Rs 10.17. Market cap stood at Rs 148.98 crore. The stock was still held at the band when this was written, so the day's gain sat with those already in the name rather than with anyone queuing behind them.

Key Takeaways

• Gujarat Inject (Kerala) Ltd. (GUJINJEC) hit the upper circuit on BSE at Rs 10.67 on 27 October 2026.
• The session move was +4.92% against a previous close of Rs 10.17.
• Market capitalisation stood at Rs 148.98 crore with a PE ratio of 49.78.
• No official company announcement or verified catalyst was confirmed at the time of writing.
• A price band is an exchange trading rule, not a view on the company or a recommendation.

Key Market Data

Metric	Value
Stock	Gujarat Inject (Kerala) Ltd.
Current Price / LTP	Rs 10.67
Day Move	4.92%
Previous Close	Rs 10.17
Day Open	Rs 10.46
Day High	Rs 10.67
Day Low	Rs 10.37
Upper Circuit Price	Rs 10.67
Upper Circuit Limit	Rs 10.67
Market Cap	Rs 148.98 crore
Selected Exchange	BSE
PE Ratio	49.78

All figures above are as of 27 October 2026, sourced from Univest market data for the BSE listing. Only fields present in the source for this session are shown.

Price Action and Trading Activity

Gujarat Inject (Kerala) Ltd. opened at Rs 10.46 on BSE, above the previous close of Rs 10.17, and dipped to a session low of Rs 10.37 before moving up to Rs 10.67, the day's high and the band price.

The gain on the previous close was Rs 0.5, or 4.92%. For a holder, the small dip below the open made no lasting difference to the day. A buyer arriving at the band meets a stock that cannot go higher in the session.

All figures are taken from BSE alone, as another exchange may use a different band or reference close, and the open here is measured against the BSE previous close.

Why Gujarat Inject (Kerala) Ltd. Hit Upper Circuit

Buying interest pushed Gujarat Inject (Kerala) Ltd. up to the limit of its exchange-defined price band. No official company announcement and no verified external catalyst stood confirmed at the time of writing, so price action and market sentiment are the only terms in which the move can be described.

This article does not assign the rise to earnings, a corporate action, sector news or market rumours. A confirmed announcement, should one come, would be handled in a separate update.

The band price reached in the session was Rs 10.67.

What the Gujarat Inject (Kerala) Upper Circuit Means

An upper circuit is the highest price an exchange allows a stock to reach in a session, and for Gujarat Inject (Kerala) Ltd. that was Rs 10.67 on 27 October 2026.

The band is there to slow sharp moves and keep trading orderly. Existing holders see the stock at the top of what the session permits; new buyers are asked to join a queue at that ceiling. Both views describe market mechanics, and neither is a forecast of returns.

Gujarat Inject (Kerala) Ltd. Fundamentals and Valuation

The figures on file for Gujarat Inject (Kerala) Ltd. give a PE ratio of 49.78, a PB ratio of 11.38, book value of Rs 0.89 and EPS of 0.2, set against a market cap of Rs 148.98 crore. Dividend yield was 0% and debt-to-assets was 0. None of this is a buy, sell or hold view.

A PB ratio of 11.38 means the shares are priced at more than eleven times reported book value per share, which is a wide gap between price and book. Growth hopes, asset quality or a thin counter could each sit behind a premium of that size. The PE ratio of 49.78 follows from EPS of 0.2 against a price of Rs 10.67.

Holders and prospective buyers each still have to review valuation and returns separately from the price event, as a one-day move leaves these ratios as they were.

Peer and Sector Context

Gujarat Inject (Kerala) Ltd. belongs to the Pharmaceuticals & Drugs industry within the Healthcare sector. The peer table below uses available companies from the same sector or industry to give broader valuation context.

Peer Company	Market Cap	PE	PB	ROE
Ind-Swift Laboratories Ltd.	Rs 2986.18 crore	52.09	2.08	3.47%
Advanced Enzyme Technologies Ltd.	Rs 2806.68 crore	16.92	1.69	11.43%
Hikal Ltd.	Rs 2402.52 crore	-	2.02	-3.97%
Fredun Pharmaceuticals Ltd.	Rs 2338.74 crore	53.37	7.67	16.09%
Beta Drugs Ltd.	Rs 2199.67 crore	42.37	5.03	18.78%

A dash in the PE column means no PE ratio was carried for that company in the source data, which happens when reported earnings are negative or have not been refreshed. Those companies are left out of the average below rather than counted as zero.

Several of these peers are far larger by market capitalisation than Gujarat Inject (Kerala) Ltd. Size differences change liquidity and cost of capital, so the table is sector context rather than a like-for-like ranking.

Gujarat Inject (Kerala) Ltd.'s PE ratio was 49.78, compared with an available peer PE average of 41.19, calculated from the 4 peer companies that had a PE on record. This comparison is a valuation reference point, not a recommendation.

Technical Snapshot

The technical snapshot adds context: RSI was 46.03, the 50-day moving average was 9.68 and the 200-day moving average was 10.37.

What Readers Should Know

One fact is settled: shares of Gujarat Inject (Kerala) Ltd. sat at the upper circuit on BSE at Rs 10.67 on 27 October 2026, up 4.92% on the previous close.

The two positions differ in practice. A holder has the gain on screen, while a new buyer may find that an order at the band goes unfilled for lack of sellers. The company had issued no confirmed trigger when this was written, which leaves the move without a stated reason.

This is a market update, not a verdict on the business. Filings, valuation, liquidity and risk each call for a separate look before any conclusion is drawn.

Frequently Asked Questions

Why did Gujarat Inject (Kerala) Ltd. hit upper circuit on 27 October 2026?

The stock reached its upper price band after buying interest during the session. No official company announcement or verified external catalyst was confirmed at the time of writing.

What was GUJINJEC share price on 27 October 2026?

The last traded price used in this article was Rs 10.67 on BSE. That price matched the upper circuit price captured for the event.

What was the upper circuit price for GUJINJEC?

The upper circuit price was Rs 10.67. The stated exchange upper circuit limit was Rs 10.67. The event numbers in this article are aligned to BSE.

What is Gujarat Inject (Kerala) Ltd.'s market cap and PE ratio?

Gujarat Inject (Kerala) Ltd.'s market cap was Rs 148.98 crore. PE ratio was 49.78.

Which exchange and data source were used?

The selected exchange was BSE. The article uses Univest market data available at the time of generation, captured on 27 October 2026.

Does hitting an upper circuit mean Gujarat Inject (Kerala) Ltd. is a buy or a sell?

No. A circuit is an exchange price-band rule that caps how far a stock can move in a single session. It carries no view on valuation or business quality and is not a recommendation. Any decision should rest on fundamentals, valuation, liquidity and your own risk tolerance.

Can you buy or sell Gujarat Inject (Kerala) Ltd. shares when the stock is at the upper circuit?

It is usually difficult. At the upper circuit, buy orders queue up while sellers step back, so there may be no counterparty at the quoted price. Orders can stay unfilled until the band opens up or sellers return.

What happens the next trading session after an upper circuit?

There is no fixed outcome. The band resets each session, so the stock can open freely, hit the same band again, or reverse. The exchange can also revise the applicable band width. The useful signals to watch are whether the company files any disclosure explaining the move.

What is the upper circuit limit set at for Indian stocks?

Exchange price bands are commonly set at 2%, 5%, 10% or 20% depending on the security, and the applicable band can be revised by the exchange. For Gujarat Inject (Kerala) Ltd. the stated limit was Rs 10.67. For this session, Gujarat Inject (Kerala) Ltd. moved 4.92%.